Paclitaxel as Albumin-Bound Nanoparticles with Gemcitabine for Untreated Metastatic Pancreatic Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

As part of the single technology appraisal (STA) process, the National Institute for Health and Care Excellence (NICE) invited Celgene Ltd to submit clinical and cost-effectiveness evidence for paclitaxel as albumin-bound nanoparticles (Nab-Pac) in combination with gemcitabine (Nab-Pac + Gem) for pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Stainthorpe, Angela, Greenhalgh, Janette, Bagust, Adrian, Richardson, Marty, Boland, Angela, Beale, Sophie, Duarte, Rui, Kotas, Eleanor, Banks, Lindsay, Palmer, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132498/
https://www.ncbi.nlm.nih.gov/pubmed/29600384
http://dx.doi.org/10.1007/s40273-018-0646-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132498/
https://www.ncbi.nlm.nih.gov/pubmed/29600384
http://dx.doi.org/10.1007/s40273-018-0646-1

Ejemplares similares